Non-viral CFTR gene delivery to the lungs of Cystic Fibrosis patients

Non-viral CFTR gene delivery to the lungs of Cystic Fibrosis patients

Bibliographic Details
Main Author:	Hyde, S
Format:	Conference item
Published:	2013

Similar Items

A randomized, double-blind, placebo-controlled trial of repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis
by: Alton, E, et al.
Published: (2015)

The effect of CFTR modulators on structural lung disease in cystic fibrosis
by: L. Clara Mok, et al.
Published: (2023-04-01)

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
by: Alton, EWFW, et al.
Published: (2016)

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
by: Eric WFW Alton, et al.
Published: (2016-07-01)

Cystic Fibrosis, CFTR, and Colorectal Cancer
by: Patricia Scott, et al.
Published: (2020-04-01)

Mutation Analysis of CFTR Gene in 70 Iranian Cystic Fibrosis Patients
by: Reza Alibakhshi Mahdi Zamani
Published: (2006-03-01)

Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
by: Giuseppe Fabio Parisi, et al.
Published: (2022-05-01)

Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
by: Davies, L, et al.
Published: (2014)

Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
by: Veselu, D-F, et al.
Published: (2024)

Common CFTR gene mutations in cystic fibrosis patients in Mazandaran province - Iran
by: Haleh Akhavan-Niaki (PhD), et al.
Published: (2008-10-01)

Functional Consequences of CFTR Interactions in Cystic Fibrosis
by: Yashaswini Ramananda, et al.
Published: (2024-03-01)

Cystic Fibrosis and Oxidative Stress: The Role of CFTR
by: Evelina Moliteo, et al.
Published: (2022-08-01)

The Cystic Fibrosis Transmembrane Regulator (CFTR) in the kidney
by: MARCELO M. MORALES, et al.
Published: (2000-09-01)

Strategies to circumvent the CFTR defect in cystic fibrosis
by: Frederic eBecq, et al.
Published: (2013-08-01)

CFTR and Ca2+ signaling in cystic fibrosis
by: Fabrice eAntigny, et al.
Published: (2011-10-01)

Not All Is CFTR – Neutrophils and Cholesterol in Cystic Fibrosis
by: Stefano Castellani, et al.
Published: (2017-10-01)

Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
by: Pringle, I, et al.
Published: (2009)

Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators
by: Carla M. P. Ribeiro, et al.
Published: (2023-03-01)

Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
by: McLachlan, G, et al.
Published: (2011)

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
by: Alton, EWFW, et al.
Published: (2015)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
by: Caitlyn Harvey, et al.
Published: (2022-03-01)

Nutritional impact of CFTR modulators in children with cystic fibrosis
by: Margaux Gaschignard, et al.
Published: (2023-03-01)

Cross‐talk between CFTR and sphingolipids in cystic fibrosis
by: Dorina Dobi, et al.
Published: (2023-09-01)

Lived experiences of individuals with cystic fibrosis on CFTR-modulators
by: Annelise Page, et al.
Published: (2022-01-01)

Apical CFTR expression in human nasal epithelium correlates with lung disease in cystic fibrosis.
by: Marit Arianne van Meegen, et al.
Published: (2013-01-01)

Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility
by: Giuseppe Fabio Parisi, et al.
Published: (2023-08-01)

The Impact of the CFTR Gene Discovery on Cystic Fibrosis Diagnosis, Counseling, and Preventive Therapy
by: Philip M. Farrell, et al.
Published: (2020-04-01)

Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators
by: Isabelle Fajac, et al.
Published: (2021-10-01)

Identification of 99% of CFTR gene mutations in Bulgarian‐, Bulgarian Turk‐, and Roma cystic fibrosis patients
by: Guergana Petrova, et al.
Published: (2019-08-01)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
by: Davies, G, et al.
Published: (2011)

"Bronchial Artery Delivery of Viral Vectors for Gene delivery in Cystic Fibrosis; Superior to Airway Delivery?"
by: Coutelle Charles C, et al.
Published: (2002-04-01)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
by: Ryosuke Fukuda, et al.
Published: (2020-04-01)

Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
by: Serena Schippa, et al.
Published: (2013-01-01)

Effects of CFTR modulators on serum biomarkers of liver fibrosis in children with cystic fibrosis
by: Steven Levitte, et al.
Published: (2023-02-01)

Impact of CFTR modulators on exercise capacity in adolescents with cystic fibrosis
by: Molla Imaduddin Ahmed, et al.
Published: (2024-02-01)

CFTR High Expresser Cells in cystic fibrosis and intestinal diseases
by: Diego Carlos dos Reis, et al.
Published: (2023-03-01)

Molecular chaperones as targets to circumvent the CFTR defect in cystic fibrosis
by: Rebecca A Chanoux, et al.
Published: (2012-07-01)

Triplet CFTR modulators: future prospects for treatment of cystic fibrosis
by: Chaudary N
Published: (2018-12-01)

Precision Medicine Based on CFTR Genotype for People with Cystic Fibrosis
by: Haq I, et al.
Published: (2022-02-01)

Predicting CFTR activity with front-runner cystic fibrosis drugs
by: Frédéric Becq
Published: (2015-02-01)